1. Home
  2. FCFS vs IBRX Comparison

FCFS vs IBRX Comparison

Compare FCFS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FirstCash Holdings Inc.

FCFS

FirstCash Holdings Inc.

N/A

Current Price

$225.62

Market Cap

9.7B

ML Signal

N/A

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.08

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCFS
IBRX
Founded
1988
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.2B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
FCFS
IBRX
Price
$225.62
$8.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$210.67
$12.57
AVG Volume (30 Days)
354.6K
7.2M
Earning Date
04-23-2026
05-08-2026
Dividend Yield
0.78%
N/A
EPS Growth
29.49
38.71
EPS
4.56
N/A
Revenue
$3,661,043,000.00
$113,288,000.00
Revenue This Year
$16.20
$88.59
Revenue Next Year
$8.35
$131.15
P/E Ratio
$48.72
N/A
Revenue Growth
8.04
668.31
52 Week Low
$145.42
$1.95
52 Week High
$238.93
$12.43

Technical Indicators

Market Signals
Indicator
FCFS
IBRX
Relative Strength Index (RSI) 54.41 53.15
Support Level $204.76 $7.77
Resistance Level $232.44 $8.51
Average True Range (ATR) 9.24 0.35
MACD 0.11 0.01
Stochastic Oscillator 50.88 41.29

Price Performance

Historical Comparison
FCFS
IBRX

About FCFS FirstCash Holdings Inc.

FirstCash Holdings Inc is an operator of pawn stores in the U.S., Latin America and the U.K. The company's primary line of business is the operation of retail pawn stores, also known as pawnshops. It also operates a retail POS payment solutions business. Its two business lines are organized into four reportable segments: The U.S. pawn segment consists of pawn operations in some of U.S. states and the District of Columbia; The Latin America pawn segment consists of pawn operations in Mexico, Guatemala, El Salvador and Colombia; The U.K. pawn segment consists of pawn operations in England, Scotland and Wales; and The retail POS payment solutions segment consists of the operations of American First Finance, LLC, which offers products in the U.S.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: